OTCM
IVPR
Market cap11kUSD
Oct 23, Last price
0.00USD
1D
0.00%
1Q
0.00%
IPO
-99.71%
Name
Inspire Veterinary Partners Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Inspire Veterinary Partners, Inc. manages and owns a network of veterinary hospitals located across the United States. The company's primary focus is general practice for small animals, catering to beloved companion pets like dogs and cats, with their services also extending to equine care. They provide an extensive range of surgical options, including common soft tissue procedures such as spaying, neutering, tumor removal, spleen removal, and stomach tacking, as well as orthopedic surgeries and other specialized interventions. In addition to traditional veterinary medicine, Inspire Veterinary Partners offers alternative and holistic treatments like acupuncture, chiropractic adjustments, and various other health and wellness services. Their facilities also prioritize comprehensive preventive care for companion animals, which includes annual health check-ups, parasite management, dental hygiene, nutritional and body condition guidance, neurological assessments, diagnostic imaging (radiology), blood analyses, skin and coat health maintenance, and other breed-specific preventative measures. Established in 2020, Inspire Veterinary Partners, Inc. is headquartered in Virginia Beach, Virginia.
Key people
Kimball Carr
Chairman of the Board, President, Chief Executive Officer · since 2021
Richard Frank
Chief Financial Officer Nominee
Laura Johnson
Vice President of Operations · since 2024
Alexandra Quatri
Vice President of Medical Operations · since 2024
Lynley Kees
Vice President of Human Resources · since 2024
Charles Keiser
Director · since 2021
Charles Keiser
Vice Chairman of the Board, Chief Operating Officer · since 2022
Kelli Kerwin
Director · since 2022
Peter Lau
Director · since 2023
Richard Marten
Director · since 2020
Larry Alexander
Independent Director
Phillip Balatsos
Independent Director · since 2022
Anne Murphy
Independent Director Nominee
John Suprock
Independent Director Nominee
Erinn Thomas-Mackey
Independent Director Nominee
Timothy Watters
Independent Director Nominee
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||